Chemify scales up operations at Health Innovation Hub 

Digital chemistry company Chemify is set to embark on the next phase of its business journey with a strategic relocation to Glasgow’s newest purpose-built life science facility, Health Innovation Hub (HiH).

Chemify, a pioneer in developing technology to provide pharmaceutical, biotechnology and industrial partners with better molecules, will occupy more than 40,000 sq ft across two floors with additional space on the ground floor of HiH. This represents the largest commercial letting of the year so far for life sciences in Glasgow, with Ryden acting for Chemify.

Designed to provide flexible laboratory and office accommodation, HiH is being delivered by Kadans Science Partner (“Kadans”), in collaboration with the Living Laboratory for Precision Medicine, a University of Glasgow-led programme that is at the forefront of translating cutting-edge science and innovation into real-world clinical settings. This flagship facility is focused on advancing and delivering precision medicine technologies through the R&D stage ahead of commercialisation.

Previously headquartered at the Advanced Research Centre (ARC) at the University of Glasgow, Chemify currently employs 165 leading scientists and specialists from around the world who will benefit from bespoke laboratories and modern workspace tailored to their needs at the new facility.

Professor Lee Cronin, CEO and Founder of Chemify, said: “Our expansion into the Health Innovation Hub marks an exciting new chapter for Chemify. This cutting edge accommodation will allow us not only to scale up our operations, but also to keep attracting the best talent while consolidating our key role in the digitisation of chemistry. We also look forward to continuing our collaboration with the University of Glasgow and contributing to the city's appeal as a burgeoning hub for artificial intelligence, advanced manufacturing, and the life sciences sector.”

Chemify joins the Digital Health Validation Lab (DHVL) who will all be welcomed as the first tenants of HiH when it opens this year. DHVL provides essential infrastructure and expertise to support innovators in building the evidence needed to guide decisions at critical points — including investment, regulatory approval, and market access. This is a partnership between the University of Glasgow and NHS Greater Glasgow and Clyde. By accelerating the development and clinical adoption of innovative solutions, it supports the Living Laboratory’s mission to tackle critical healthcare challenges and improve patient outcomes.

Mark Hanna, Director of Asset Management of Kadans Science Partner added: “We constantly hear about the need and opportunity for life science space to improve Scotland’s health and economic outcomes. With a proven track record in Europe and the rest of the U.K. Kadans is making this happen through the Health Innovation Hub, supporting the life science sector and helping businesses thrive within dynamic ecosystems. It’s a very exciting time as we are near completion of HiH. We are very proud to welcome Chemify and provide them with a very fitting world class environment to support their growth. Chemify’s presence reinforces the HiH’s role as a focal point for research, collaboration and commercialisation in life sciences, making it an ideal environment to support scientific innovation and foster talent.”

Opening in Autumn 2025, Health Innovation Hub is the first of its kind in Glasgow, poised to revolutionise precision medicine technologies from R&D to commercialisation. It offers 87,000 sq ft of highly flexible lab and office space catering to everything from university spinouts to established operations.

The Health Innovation Hub is located within the Glasgow Riverside Innovation District (GRID) - a dynamic and inclusive innovation district located on the banks of the River Clyde where communities, industry, public sector and academia are driving transformational change. The site also lies adjacent to the Queen Elizabeth University Hospital, and forms part of a growing Health & Life Sciences cluster within GRID. This strategic placement of HiH will create a dynamic environment to accelerate scientific breakthroughs, cement Glasgow’s leadership in the life sciences sector, and unlock long-term economic opportunities for the area.

About Kadans

Kadans Science Partner is the European leader investing in the development of ecosystems and real estate with a dedicated focus on knowledge-intensive sectors. We focus on bringing people together to overcome global challenges. Therefore, we invest, develop and operate specialised assets to complement science clusters. Across Europe, we have built a network of clients, partner organisations, and innovative minds, active in Life Sciences & Health, Agri & Food, Energy & Chemistry, and High Tech Systems & Materials. All determined to find solutions to the global challenges we face today. Currently already active in 30+ science clusters, our network continues to grow as we develop more locations and support more clusters across Europe.

About the Living Laboratory for Precision Medicine

The Living Laboratory for Precision Medicine is a University of Glasgow-led programme that accelerates the development, evaluation, and adoption of innovative healthcare solutions into real-world clinical settings. Rooted in collaboration, it brings together researchers, clinicians, and industry partners in a ‘triple helix’ partnership, harnessing their collective expertise to drive innovation into frontline healthcare. Through this concerted effort, the programme aims to improve patient outcomes, deliver significant cost savings for the NHS, and stimulate economic growth in Govan, Glasgow, and beyond.

About the University of Glasgow

Founded in 1451, The University of Glasgow is a world-class university, committed to working with global partners to create high-quality research with real-life impact. 

We were named the Scottish University of the Year by the Times & Sunday Times Good University Guide 2024 and have been home to world-changing research and teaching for more than 570 years. 

Our research excellence responds to some of the world’s greatest challenges in areas such as precision medicine and chronic diseases, one health, future life, addressing inequalities, cultural and creative economies, and the nano and quantum world.

About Chemify

Chemify is reimagining the discovery and synthesis of novel molecules for medicines and advanced materials by turning digital code into physical compounds through Chemputation—its fusion of robotics and AI. Headquartered in Glasgow, Scotland, the company was founded by Lee Cronin to digitalise chemistry at global scale for the benefit of humanity.